
Levoketeconazole
Levoketeconazole is used to treat Cushing syndrome by inhibiting cortisol production.
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Levoketeconazole – CAS 65277-42-1
CAS Number
65277-42-1
Category
Cushing syndrome
Therapeutic Class
Steroidogenesis inhibitor
Description
Levoketeconazole is used to treat Cushing syndrome by inhibiting cortisol production.
Applications
- Cushing syndrome
- Hypercortisolism
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.